Finance

A Silicon Valley Bank report reveals that healthcare sectors experienced strong growth in AI deal activity, especially in healthtech and biopharma.

While most provider and payer organizations are using some form of AI, very few are getting demonstrable value at scale across the enterprise, says Tom Lawry, managing director of Second Century Tech.

The company will use the funds to develop its employee assistance program platform, expand global clinical access and increase partnerships.

When it comes to making strategic AI investment deals, companies need to articulate their competitive advantage and how they view the market around them, says Jason Smith, venture acceleration fellow at MATTER.

The company will use the funds to augment key content partnerships.

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

Managing AI agents and prompt engineering is not like standard software engineering, and no one has really figured out how to do it at scale reliably yet, says Dr. Lukasz Kowalczyk, a gastroenterologist and CEO of Soothien HealthTech Advisory.

Proceeds will go to settling debts and focusing on its business in the United States.

Mark Newman, founder and CEO of Nomi Health, recommends driving accountability on fully automating payments for primary care visits to providers. He says there is no reason why they should be delayed or slow.